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Abstract
Bioprinting is an emerging field in the areas of tissue engineering and regenera-
tive medicine. It is defined as the printing of structures consisting of living cells, 
biomaterials and active biomolecules. The ultimate aim is to produce implant-
able organs and tissues to replace the use of autografts, which cause donor site 
morbidity and require two invasive surgeries. Not only is bioprinting aimed at 
the restoration of tissue, it has significant potential for drug delivery and cancer 
studies. Bioprinting provides control over cell placement and therefore creates a 
homogenous distribution of cells correlating to a uniform tissue ingrowth. Another 
attribute of bioprinting is the production of patient-specific spatial geometry, 
controllable microstructures and a high degree of reproducibility and scalability 
between designs. This book chapter will discuss the many parameters of bioprint-
ing; manufacturing techniques, precursor materials, types of printed cells and the 
current research.
Keywords: inkjet printing, extrusion, stereolithography, laser-assisted, 
tissue engineering, hydrogel, bioink, additive manufacture, 3D printing
1. Introduction
There are more organ donors and recipients than there have ever been, however, 
in the UK, up to one in six patients requiring either a liver, heart or lung transplan-
tation becomes too ill or dies while waiting for a donor organ [1]. When a donor 
organ becomes available, the recipient and clinicians have to make a fast decision 
whether to accept the organ, which can lead to an improper assessment of the 
associated risks. Risks associated with the donor organ include the age of the donor, 
retrieval of the organ after circulatory death and the potential to transmit blood-
borne disease or cancer [1].
Bioprinting has the potential to eradicate the problems associated with organ 
donation and provide implantable organs on-demand. Bioprinting is a subcategory 
of additive manufacture, a process by which small scale objects are printed from 
a bottom up approach, through the deposition of successive layers of material. 
Using this approach enables the production of very precise and accurate designs 
and shapes to be built using minimal amounts of material. Designs are made on a 
computer which is then sent to a printer, meaning that designs are highly repeat-
able. The processes for developing a bioprinted tissue are outlined in Figure 1.
Although additive manufacturing uses a variety of materials to fabricate objects 
with different functions and purposes, bioprinting is specifically the printing of 
structures consisting of living cells, biomaterials and active biomolecules. First 
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patented attempts of bioprinting started with filling cartridges of table-top inkjet 
printers with bioinks, consisting mainly of cell-laden hydrogels [2]. Although 
research using inkjet technology was an early adapter for bioprinting, many other 
additive manufacturing techniques have also been utilized.
Common techniques include inkjet printing, stereolithography and extrusion 
printing, demonstrated in Figure 2. Although these techniques are well established, 
it is only in the last decade that these processes have been properly developed for 
applications in the field of regenerative medicine and tissue engineering. Compared 
to the conventional techniques of producing tissue engineering scaffolds, additive 
manufacture has the ability to consistently produce highly repeatable designs with a 
precise, well-defined micro and nanoscale structure [3, 4].
The ultimate goal of bioprinting is to produce an entire complex organ capable 
of being implanted. This will provide an alternative source of organs so that patients 
will no longer require long waiting periods to receive a donor organ. Additionally, 
by being able to fabricate organs on demand, the ethical issues surrounding the 
supply and use of human or animal tissues is removed.
Another possibility for bioprinting is to provide an alternative to animal testing. 
The potency and dosages of pharmaceuticals can be tested on bioprinted organoids 
or on an “organ-on-a-chip”. This could prove to be a more efficient and effective 
Figure 1. 
Flow chart depicting the individual process involved with producing a bioprinted tissue.
Figure 2. 
Bioprinting techniques: (a) extrusion-based, (b) inkjet-based, (c) stereolithography and (d) laser-assisted.
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method for the testing of pharmaceuticals, as the translation from an animal model 
in to humans is not without its flaws, as an animal system cannot fully replicate a 
human system.
Common tissue engineering manufacturing techniques are capable of producing 
tissue specific scaffolds; however they require to be seeded with cells post-fabrica-
tion. Cell seeding post-fabrication can lead to a poor distribution of cells, especially 
in larger scale 3D scaffolds. Homogeneous distribution of cells is not a problem 
with bioprinting, as printing can be used to control the positioning of cells during 
fabrication [5].
Simple tissues have been repaired in a clinical setting using tissue engineering 
scaffolds, such as the larynx [6], bladder [7] and urinary tract [8], however through 
bioprinting, the ability to build a more complex tissue scaffold for implantation 
becomes a greater prospect.
2. Printing techniques
2.1 Inkjet printing
Inkjet printing is a non-contact method of fabrication, which limits the risk of 
contamination during printing. Scaffolds are constructed using the deposition of 
droplets and can achieve excellent resolution ranging between 20 and 100 μm [9–11]. 
Droplets are ejected from a printhead via thermal, piezoelectric or microvalve pro-
cesses. Thermal inkjet printing uses the nucleation of an air bubble to induce droplet 
formation, but a localized temperature between 100 and 300°C could inflict damage 
on cells and limits its use for printing natural polymers [10, 12]. Piezoelectric-based 
inkjet printing uses acoustic waves to eject a droplet, however this limits the use of 
viscous and therefore more concentrated inks, as these will dampen out the acoustic 
waves before they can expel a droplet [13]. Microvalve printing uses pneumatically 
controlled pistons to eject droplets. Inkjet printing can print multiple inks at once 
that can be used to interact with each other to control scaffold properties and create 
complex structures with multiple types of cells [14–16].
2.2 Extrusion
Bioink is extruded from a micro-nozzle to build a three-dimensional structure in 
layer-by-layer fashion. Extrusion-based printing is either mechanically (piston or 
screw) or pneumatically driven [9]. This fabrication technique uses highly viscous 
bioink and does not require any chemical additives to enable the curing of the 
material [9]. As inks are viscous, and therefore more concentrated, fabrication rates 
are relatively quick. However, the more viscous a bioink is, the higher the induced 
shear-stress during extrusion, which can result in a higher cell apoptotic activity. 
Out of the different extrusion bioprinting techniques, pneumatic systems have 
demonstrated the best cell viability post printing [17]. Extrusion-based techniques 
are promising as they create scaffolds with high structural integrity using bioinks 
containing high cell densities and can achieve resolutions around 200 μm [9, 18].
2.3 Laser-based printing
There are two laser-based techniques used for bioprinting. The first is stereo-
lithography (SLA), which is a nozzle-free technique that depends on photocuring 
with ultraviolet light (UV). The UV energy is directed at a reservoir of photosensi-
tive polymers to formulate 3D structures in a layer-by-layer fashion. This technique 
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is known to have quick fabrication times as its speed depends on the height of the 
print rather than on the print complexity [19]. A resolution ranging between 5 and 
300 μm can be achieved using SLA [20, 21]. This technique is not limited by the 
viscosity of the bioink, however, photoinitiators are often added to the bioink to 
improve polymer photosensitivity, and can affect the viability of the cells. The type 
and concentration of photoinitiator will influence cell viabilities differently [19]. 
Another concern is UV-induced damage to the cells, and has led to the development 
of alternative visible light-based and initiator-free techniques [22, 23]. Collectively, 
the short fabrication time and the absence of shear stress-induced apoptosis make 
SLA a good candidate for bioprinting.
Another laser-based bioprinting technique is laser-assisted bioprinting (LAB), 
which is a scaffold-free and nozzle-free technique where droplets of biomaterial/
cells/peptides are propelled from a donor material slide onto a receiver material. Laser 
energy induces a vaporization effect used to transfer material from the donor mate-
rial slide onto the receiver. This technique can achieve a micro-scale resolution with 
multicell positioning [24, 25]. The accurate positioning of multiple cell types using 
this technique has great potential in creating biologically relevant complex designs, 
yet the main drawbacks of this technique are its low stability and scalability [24].
3. Bioinks
Bioink is a term given to the precursor material used during printing. The main 
component of the bioink usually consists of a hydrogel. Hydrogels are used as they 
are highly hydrated, enable cell encapsulation and provide a cushioning effect 
during fabrication. Furthermore, hydrogels have adaptable rheological properties 
making them suitable for processing and printing [15]. Hydrogels used in tissue 
engineering applications are either naturally derived or synthetically derived 
polymers.
3.1 Naturally derived hydrogels
Collagen, gelatin (denatured collagen), silk, alginate and chitosan are the most 
commonly used naturally derived polymers in bioprinting with collagen being used 
in 26% of the bioprinting-relevant literature [26]. Natural polymers provide great 
bioactivity and high adhesiveness, resulting in high cell viability and proliferation. 
However, a lack of mechanical competence and reproducibility limit their use in a 
non-composite form.
3.2 Synthetically derived hydrogels
Aliphatic polyesters and poly(ethylene glycol) are the most commonly used 
synthetic polymers in bioprinting [27]. Synthetic polymers have a high printing 
fidelity and controllable degradation kinetics and mechanical properties. However, 
their inert properties result in low cell viability and proliferation rate [28]. Aliphatic 
polyesters used in tissue engineering are usually poly(lactic acid), poly(glycolic 
acid) and poly(caprolactone). Refer to Table 1 for a comparison of their different 
properties.
3.3 Characteristics
When processing bioinks, three main parameters must be considered: viscosity 
of the precursor hydrogel, gelation and network stiffness post-processing [30]. 
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The latter two points can affect cell viability, proliferation, migration and even 
differentiation. The three parameters are mainly affected by the type of polymer, its 
concentration and molecular weight. Other factors that can have an adverse effect 
on cells are the shear stress induced during printing and the time period during 
which the cells are exposed to non-physiological conditions (fabrication time).
Rheology of the bioink, particularly viscosity, is an important consideration for 
printing. Viscosity affects printing fidelity and also influences the shear stresses 
induced during printing. High shear stresses during printing can damage cells in 
nozzle-based techniques leading to higher cell apoptotic activity. Each printing 
technique requires a different viscosity range; inkjet-based printers require low 
viscosity solutions [31], extrusion-based printers require a high viscosity [9], while 
laser-assisted bioprinting requires a medium viscosity [5]. However, stereolitho-
graphic techniques are not as limited by hydrogel viscosity ranges. Recent research 
has shown that the sheer stresses induced by the applied pressure in extrusion 
printing can be alleviated if the bioinks are prepared as isotonic solutions [32].
The objective to have a 3D structure laden with cells that are viable, proliferative 
and differentiative, along with a structure that exhibits mechanical competence, 
stability and biologically relevant complexity is dependent on the bioink and the 
printing process. Ultimately, the type of polymer, its chemical properties, viscos-
ity, gelation, stiffness and fabrication time will affect the cells’ status and the print 
fidelity.
4. Bioprinted tissues
4.1 Neural
Injuries of the central and peripheral nervous system can be challenging to 
repair. The central nervous system does not regenerated under normal conditions, 
and any injuries it sustains can lead on to neurogenerative disease. Damage to the 
peripheral nervous system is mostly treated with autografts and allografts, however 
motor and sensory recovery rates are poor. In a review of studies recording sensory 
recovery after digital nerve repair, only 67% of patients reported good sensory 
repair or better with a nerve graft, which increased to 79% of patients with artificial 
conduits [33]. This result indicates the potential for synthetically made nerve guid-
ance conduits and therefore the use of bioprinting.
Some of the initial work involving bioprinting of mammalian cells was performed 
using Chinese hamster ovary (CHO) and rat embryonic motoneuron cells [34]. 
It was established that using an inkjet printer to print the cells did not affect cell 
proliferation or the polarized morphology of the motoneuron cells. However, 
Aliphatic 
polyester
Hydrophilicity/hydrophobicity Degradation 
time
Young’s 
modulus [29]
PCL Very hydrophobic Lowest 0.4 GPa
PLA Hydrophobic Medium 2.7 GPa
PGA Hydrophilic Fast 7.0 GPa
PLGA Ratio of different polymers will influence rate of degradation and water 
affinity; PLA percentage means mixture has lower degradation rate and 
is more hydrophobic.
Amorphous
Table 1. 
Correlation between water affinity and degradation rate for aliphatic polyesters.
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evaluation of cell lysis immediately after printing indicated that ~8% of the cells 
were damaged due to the printing process. Further work with rat primary embry-
onic hippocampal and cortical neurons demonstrated a cell viability of 74.2 ± 6.3%, 
as well as the maintenance of basic function, phenotype and electrophysiological 
properties [35].
Lorber et al. inkjet printed cells from the mature adult nervous system [36]. 
Monitoring the cells during droplet ejection, the cells did not undergo major distor-
tion and hence destruction caused by shear forces. It was shown that printed glia 
cells retained their ability to support the growth of the seeded retinal ganglion cells, 
which is an essential interaction for maintaining proper nerve function. Tse et al. 
printed a combination of neuronal and glial cells [37]. High cell viabilities >86% for 
neuronal cells and >89% for Schwann cells were achieved. Not only did the printed 
cells exhibit early neurite growth in comparison to non-printed cells, neurites also 
grew longer in length.
Using an extrusion printing process, neural stem cells (NSCs) have been printed 
embedded in polyurethane (PU) [38]. The bioprinted scaffolds restored nerve 
function when used to treat Zebra fish with a traumatic brain injury. Owens et al. 
developed the extrusion bioprinting process to produce purely cellular nerve grafts 
[39, 40]. Mouse bone marrow stem cells (BMSCs) and Schwann cells (SC) were 
extruded alongside agarose rods. The agarose rods were removed after a 7 day matu-
ration period leaving a tubular cell structure. Implanted to repair a sciatic nerve 
injury in rats, both motor and sensory function was restored after 40 weeks.
SLA has been used to print human neural stem cells (hNSCs) [41]. Scaffolds 
were made containing GelMA and graphene nanoplatelets. GelMA content had a 
negative effect on cell proliferation rates, while the presence of graphene, known to 
stimulate hNSCs into neural differentiation [42], improved the cellular response. 
By monitoring glial fibrillary acidic protein (GFAP) expression, which is associated 
with the development of ependymal cells, and ß-tubulin III, which is associated 
with neurons, it was determined that the printed cells had differentiated over a 
14 day period post-printing.
4.2 Skin
In the repair of deep partial thickness and full thickness burns a new epidermal 
barrier needs to be established, this is usually achieved through transplantation 
[43]. Current treatment techniques, including split thickness grafts, lack the inclu-
sion of structures such as hair follicles, subcutaneous glands or sweat glands and do 
not provide the full restoration of sensory and motor neurons [43]. This can cause 
problems for the patient, especially the lack of sweat glands, which can prevent 
proper thermo-regulation. Bioprinting can be used to develop a complex tissue as 
multiple inks can be printed at once. Although the production of replica human 
skin has yet to be achieved, there have been many promising advances for the treat-
ment of full thickness wounds.
Laser-assisted bioprinting was tested for the printing of different skin cells: 
fibroblasts and keratinocytes, as well as human mesenchymal stem cells (hMSCs) 
[25]. Printing was shown not to induce apoptotic activity and cell viabilities were 
measured as >90%. The hMSCs maintained their phenotype, implying that the 
transfer process did not induce differentiation of the cells.
Kim et al. bioprinted a skin model using both extrusion and inkjet technologies 
[44]. A collagen/PCL ink was extruded to form the basis of the scaffold, followed 
by the inkjet printing of primary human dermal fibroblasts (hFBs) and primary 
human epidermal keratinocytes (hKCs). Using inkjet printing to deposit the cells 
provided a controllable and even distribution. When placed in cell culture over a 
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14 day period, the bioprinted construct developed biological characteristics such as 
elongated hFB, and dermal and epidermal layers.
A PEG based skin model was produced by Rimann et al. [45] using a microvalve 
droplet system. Alternate layers were printed of a PEG-based ink followed by the 
hFBs ink suspension. Each layer of the PEG based ink was immediately polymerized 
using UV light. Due to the use of UV light the cells were analyzed for UV damage. 
By comparing printed and unprinted cells, it was shown that the cell DNA was not 
damaged during the printing process. The cells adhered to the structure, maintain-
ing a typical morphology and were well dispersed within the polymer matrix. After 
a 3-week period, the cells continued to proliferate and produce their own extra cel-
lular matrix, however, subsequent seeding of hKCs on top of the printed scaffolds 
did not achieve a fully stratified epidermis when exposed to the air-liquid interface 
for 14 days.
A more complex bioprinted skin model has been achieved by printing multiple 
cell types [16, 46, 47]. Using a microvalve droplet system, initial investigatory work 
used both hFBs and hKCs suspended in cell media that were printed in-between 
layers of a printed collagen gel [46, 47]. Using a droplet based technique enabled 
the precise placement of cells, with a recorded 68 ± 13 hKCs per droplet and 93 ± 13 
hFBs per droplet for each respective ink suspension. Compared to skin tissue scaf-
folds that had used a manual seeding technique, the bioprinted scaffolds retained 
their shape better and developed denser epidermal layers. The epidermal layers 
formed tight junctions between neighboring cells, an important feature of the 
epidermis for providing an effective barrier.
Further work included pigmentation of the printed skin model by printing 
human epidermal melanocytes (hMCs) into the epidermal layer [16], demonstrated 
in Figure 3. The hKCs reached a terminal differentiation to form a stratum cor-
neum-like structure. hMCs started producing melanin which accumulated at hKC 
interfaces, causing a light pigmentation. When the hMCs were printed as a uniform 
layer, they formed nevus-like structures (freckles), however it was suggested that 
this could be prevented by controlling hMC cell densities to create a more even 
spatial distribution.
A collagen skin scaffold containing hFCs and printed human dermal micro-
vascular endothelial cells (hMVECs), that was subsequently seeded with neonatal 
hKCs mixed in collagen, was compared to a commercial graft (Apligraf®) for 
treating full thickness skin wounds in mice [48]. After 14 days, the bioprinted scaf-
folds had adhered to the wound while the Apligraf® had dried out and detached 
from the implant site, although no infections were recorded for any of the test 
groups. Complete closure of the wound occurred first for the bioprinted scaffold 
after 21 days, followed by the Apligraf® after 28 days. Wound sites treated with 
either the commercial graft or the bioprinted graft developed epidermal and dermal 
Figure 3. 
Bioprinted pigmented skin model fabricated using a microvalve droplet technique [16]. Fibroblasts are used for 
a dermal layer, and keratinocytes and melanocytes for an epidermal layer.
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layers, however the bioprinted skin graft was shown to have the most histologically 
similar appearance to native skin, and developed a micro-vessel network.
Skardal et al. successfully demonstrated in-situ bioprinting to repair full thick-
ness skin wounds on the backs of mice [49]. Amniotic fluid-derived stem (AFS) 
cells and bone marrow-derived mesenchymal stem cells (MSCs) were separately 
suspended in fibrinogen-collagen solutions and printed into the wound sites. The 
fibrinogen-collagen solution was crosslinked by printing a thrombin solution 
between each layer. Printing the skin graft directly into the wound site achieved 
complete coverage of the wound and a tight seal between the skin and graft. At all 
points during the study, wound contraction and re-epithelialization were signifi-
cantly higher in wound sites treated with bioprinted cells. Printed scaffolds exhib-
ited re-epithelialization of up to 89% which had organized, well defined layers, 
while the control only exhibited a 51% re-epithelialization with a poor structural 
quality.
4.3 Cardiovascular
Cardiovascular disease is one of the major causes of death globally. According to 
World Health Organization (WHO), cardiovascular disease accounts for more than 
one third of the total deaths each year [50, 51]. Depending on severity, treatment 
solutions may require replacement of damaged vital vasculature, or even heart 
transplantation. Problems such as organ shortages or requirements for multiple 
invasive surgeries mean that alternative solutions need to be found.
Different methods have been explored for the bioprinting of a 3D vascular 
network. Endothelial cells have been successfully printed with a high degree of 
accuracy using an inkjet printer. It was shown that during printing, a precise num-
ber of cells were ejected per drop [52]. Boland et al. used inkjet printing to print a 
crosslinking agent (calcium chloride) into an alginate/gelatin solution to produce 
vascular structures [53]. By printing a crosslinking agent into the polymer solution, 
a structure was formed out of hollow shells providing a microscopic porosity that 
proved beneficial for cell migration.
Cui et al. used inkjet printing to encapsulate human microvascular endothelial 
cells (hMVEC) in a fibrin hydrogel [54]. Scaffolds were fabricated with micron-
sized fibrin channels that had similar mechanical properties to other tissue 
engineered blood vessels. In cell culture, the cells aligned along the channels in a 
confluent lining, and had formed a ring-shaped microvasculature that sealed the 
fibroin channel with a high level of integrity.
Extrusion bioprinting has been used to print heart valve conduits [55]. Scaffolds 
were fabricated using a bioink of methacrylayed hyaluronic acid (Me-HA) and 
methacrylated gelatin (Me-Gel) with suspended human aortic valvular interstitial 
cells (hAVIC). In cell culture, cells adhered and formed a monolayer on the surface 
of the bioprinted structure while the encapsulated cells below the surface started to 
remodel the hydrogel after 3 days.
Initial work into printing cardiac tissue was performed using alginate hydrogel 
and primary feline adult and human H1 cardiomyocytes [56]. Inkjet printed in a 
half heart shape, scaffolds had a 1 cm inner diameter and two connected ventricles. 
Due to the printed porosity, the large structure enabled the transportation of 
nutrients, and meant that the cells remained viable when placed in cell culture. 
Using electrical stimulation, the cardiac cells were observed to contract rhythmi-
cally which in turn caused the whole structure to beat periodically.
The generation and use of human pluripotent stem cell (iPSCs) is of grow-
ing interest for many applications as they can differentiate into multiple cell 
lineages [50]. Zhang et al. demonstrated a bioprinting methodology to fabricate 
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endothelialized myocardium using iPSCs [57]. GelMA and iPSC scaffolds were 
extruded and seeded with cardiomyocytes to induce the formation of myocardium. 
The fabricated scaffolds were capable of spontaneous and synchronous contraction 
using low level electrical stimuli.
4.4 Bone
An aging population and the use of bone grafts to augment bone for repair and 
regeneration, have led to an increasing demand of functional bone grafts. The 
current gold standard of treatment involves autologous bone retrieved from the 
patients’ iliac crest, however this requires multiple surgery sites, is expensive to 
perform and increases the associated risks involved with a second surgery site [58]. 
Therefore an alternative solution, such as the development of bioprinted bone grafts, 
presents an attractive alternative.
Using SLA, stem cells derived from mouse bone marrow stromal cells (OP-9 
cells) were embedded in crosslinked PEGDA hydrogels [59]. After 24 h, the 
cells remained viable and subsequent seeding of mouse mesenchymal stem cells 
(mMSCs) onto the scaffold showed intensive mineralization.
Catros et al. used LAB to position osteosarcoma cells (MG63) onto 
poly(caprolactone) (PCL) scaffolds [60]. Cells were printed either between lay-
ers of electrospun PCL or only as a final layer. In vitro testing initially showed no 
difference in proliferation rate between the two groups, however, after 14 days, the 
scaffolds that included printed cells between layers of PCL exhibited a significantly 
higher proliferation rate. When implanted in calvarial defects in mice, significant 
bone tissue ingrowth was observed that had an organized structure. Extruded PCL 
scaffolds containing decellularized bone matrix and human adipose-derived stem 
cells (hASCs) used for craniofacial regeneration in mice, showed improved bone 
regeneration in comparison to a pure PCL scaffold [61].
Using a bioink consisting of either a matrigel or matrigel and alginate, endothe-
lial progenitor cells (EPCs) and multipotent stromal cells (MSCs) were extruded 
into bone tissue scaffolds [62]. Implanted into subcutaneous dorsal pockets of mice, 
the scaffolds without the inclusion of alginate performed better, as they developed a 
bone-like tissue structure.
Zhou et al. employed a table-top stereolithographic printer to create biomimetic 
bone matrices to study metastasis of bone cancer in bone tissue [63], as shown 
in Figure 4. Scaffolds containing osteoblasts and hMSCs suspended in hydrogels 
containing different concentrations of GelMA and nanocrystalline hydroxyapatite, 
were subsequently seeded with breast cancer cells (BrCas). Placed in cell culture, 
osteoblast proliferation rates were observed to decrease, while BrCas proliferation 
rates increased. Interactions between the cell types within the bioprinted model 
led to the conclusion that the osteoblasts and MSCs secrete macromolecules that 
promote BrCas growth.
4.5 Cartilage
Because of its avascular nature and the presence of low cell densities, cartilage 
defects will not completely self-regenerate [64]. It is therefore important that differ-
ent treatment possibilities are investigated to initiate its’ regeneration.
Xu et al. fabricated a loadbearing cartilage scaffold using an inkjet printer to 
bioprint rabbit articular chondrocytes suspended in a fibrin–collagen hydrogel 
onto an electrospun PCL matrix [65]. It was found that by including a PCL fibrous 
network within the scaffold, mechanical properties were significantly increased. 
Scaffolds implanted subcutaneously in mice developed a dense, well organized 
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collagen, not present in the control group (unseeded scaffolds). The cartilage tissue 
formation within the bioprinted scaffolds appeared histologically similar to normal 
elastic cartilage.
The use of PCL to provide structural support was also employed by Schuurman et al., 
who extruded bioprinted GelMA embedded with chondrocytes [66]. For improved 
cartilage development, scaffolds were also fabricated with a GelMA/hyaluronic acid 
hydrogel. The inclusion of hyaluronic acid improved cell viability in vitro, however 
when implanted in mice, both scaffolds types achieved similar levels of cartilage tissue 
formation. Other extruded PCL-alginate gel scaffolds that contained chondrocytes also 
reported the formation of cartilage after being implanted into the dorsal subcutaneous 
space of mice [67].
In situ bioprinting has been investigated by Cui et al. using human chondrocytes 
suspended in a poly(ethylene glycol) dimethacrylate (PEGDMA) solution [68, 69]. 
Scaffolds were printed directly into osteochondral plugs that had been harvested 
from bovine femoral condyles. Compared to scaffolds fabricated outside of the 
defect, the in situ bioprinted scaffolds had enhanced tissue integration. Another 
in situ bioprinting method has been developed by O’Connell et al. [70]. Based on 
an extrusion bioprinting technique, an “in-situ biopen” has been made comprising 
of two ink chambers and an extruder nozzle with a UV source that enables direct 
application of a bioink during surgery. Using the biopen, a human infrapatellar 
fat pad adipose stem cell (IPFP) laden gelatin-methacrylamide/hyaluronic acid-
methacrylate (GelMA/HAMa) hydrogel scaffold was fabricated for in vitro testing. 
It was observed that the viability of biopen printed cells was 97% after 7 days.
4.6 Muscle
Bioprinting has shown great potential for building highly hierarchically orga-
nized cellular structures that comprise muscle tissue. Miri et al. created hierarchical 
cell-laden structures to mimic multicellular tissues [71]. Using extrusion-based 
bioprinting, multiple bioinks were deposited onto microfluidic chips. Structures 
resembling musculoskeletal junctions were printed using poly(ethylene glycol) 
diacrylate (PEGDA) and GelMA that were loaded with NIH/3T3 fibroblasts and 
C2C12 skeletal muscle cells. In vitro, the chips retained their printed interfaces 
Figure 4. 
Stereolithographic process to fabricate a cell-laden bone model to study breast cancer metastasis.  
(1) Homogenous suspension of MSCs and osteoblasts in a photocurable hydrogel; (2) cell-laden 3D structure 
that is seeded with breast cancer cells; (3) a close-up of homogeneously adhering MSCs/osteoblasts and a 
suspension of breast cancer cells.
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and demonstrated adequate proliferation rates. PEGDA-framed chips that had a 
concentration-gradient of methacrylated gelatin (GelMA) ranging from 5 to 15%, 
were implanted subcutaneously in rats. After 30-days, enhanced cell proliferation 
was reported for regions containing 10% GelMA, signifying a great potential for 
angiogenesis. This study demonstrates the possibility to create hierarchically cell-
laden structures to mimic multicellular tissues.
Bajaj et al. used stereolithography to bioprint muscle tissues composed of mouse 
embryonic stem cells (mESCs) and mouse myoblast cell line (C2C12), embedded 
in PEGDA [72]. Live/dead staining showed a slight decrease in cell viability for the 
bioprinted scaffolds, possibly due to the non-adhesive properties of PEGDA.
4.7 Periodontal
Periodontitis is a chronic inflammatory condition resulting in total destruction 
of the periodontium consists of alveolar bone, cementum, gingiva and periodon-
tal ligaments and if left untreated, can result in tooth loss [73, 74]. Periodontal 
ligament stem cells (PDLSCs) have been shown to support the regeneration of 
periodontal tissues [75]. Ma et al. investigated cell viability of extruded PDLSCs 
encapsulated in a GelMA/PEG hydrogel [76]. It was shown that cell viabilities were 
around 94% after 24 hours post printing. Extrusion printing has also been used to 
reconstruct the maxillary bone in a 12-year-old dog, and is believed to be the first 
case of maxillary bone reconstruction using a 3D printed scaffold [77].
4.8 Corneal
Diseases of the cornea have a significant impact on visual health worldwide. 
Corneal opacity is the fourth leading cause of bilateral blindness globally [78, 79]. 
A total of approximately 50,000 corneal transplantations were performed in the 
United States in 2013 [80–82], yet drawbacks to this procedure include a reduced 
quality of visual recovery due to an early endothelial cell loss, detachment of the 
posterior lamellar grafts and vascular in-growth into the lamellar plane [79]. 
Using sodium alginate and methacrylated type I collagen mixed with corneal 
keratinocytes, Isaacson et al. extruded corneal scaffolds [83]. To produce a concave 
structure, gelatin was used as a support material and had a hollowed out shape. 
Cell viability of cornel keratinocytes were 90% after 1 day post-fabrication which 
dropped to 83% after 7 days.
The limbus borders the cornea and provides it with limbal epithelial stem cells 
(LESCs) for regeneration. Damage caused to it by disease or injury can impair a 
person’s vision [84]. Using laser-assisted bioprinting Sorkio et al. printed human 
embryonic stem cell derived limbal epithelial stem cells (hESCs-LESCs) and hASCs 
for the repairing of the limbus [85]. Ex vivo assessment of the structures was per-
formed on porcine corneal tissue, with results compared to commercially available 
acellular Matriderm® sheets as a control. The bioprinted scaffolds exhibited strong 
adhesion with the host tissue enabling hASCs migration, while control group had a 
more limited response.
5. Conclusion
Bioprinting has been used to create a variety of complex tissues and has dem-
onstrated great potential as an alternative to autologous, allogeneic and xenogeneic 
organ and tissue transplantation. Progress towards a complete implantable organ is 
at various stages of development depending on the organ or tissue to be fabricated.
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Some of the greatest developments have been with neural and skin tissues. It has 
been shown that neuronal cells can be printed without affecting their function or 
phenotype. In one investigation using an inkjet printer, the printed neuronal cells 
demonstrated faster and longer neurite growth in comparison to non-printed cells 
[37]. When implanted, bioprinted neural scaffolds have been able to restore nerve 
function [38–40].
Complex structures such as skin have been fabricated that include both dermal 
and an epidermal layers. By using bioprinting technology, it is possible to create a 
skin model with pigmentation [16]. Bioprinted skin scaffolds have been successfully 
applied via direct in situ printing [48]. Used to repair full thickness wounds in mice, 
in situ bioprinted scaffolds have regenerated skin tissue with a histologically similar 
appearance to native skin.
A potential use for bioprinted tissues could be in modeling diseased tissues. 
Research has already been conducted studying the metastasis of bone cancer in 
a bioprinted bone tissue model [63]. Using bioprinted tissue models it could be 
possible to gain a greater understanding of the interactions between infected and 
diseased cells with healthy tissues. By doing so, new treatments can be produced 
and tested to determine the most effective solution.
Each bioprinting technique has demonstrated the potential to generate fully 
functional organs, which in the future can be used for applications such as: direct 
implantation, to fill the gap for much needed donor organs; provide a model system 
for pharmaceutical testing, and replace the necessity for animal testing; or be used 
for disease modeling and enable different treatments to be easily explored. Overall, 
bioprinting is gaining substantial interest in the field of tissue engineering and 
regenerative medicine due to its capability to produce complex organs and tissues.
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